Molecular Diagnostics
Assay Predicts Patient Survival After Nonsquamous NSCLC Resection
A molecular diagnostic assay differentiates between patients at high, intermediate, or low risk of early death after surgery to remove a nonsquamous, non-small-cell lung cancer, the most common form of lung cancer. More...02 Feb 2012
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
 Assay.jpg)
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Clinical Informatics Platform
CLARION™
Steam Sterilizer
Hi Vac II Line
In Other News
Biomarker Improves Head and Neck Cancer Patient Prognosis
High Risk Cancer Gene Discovered
Genetic Key Found for Cancer Patient's Treatment Failure
Hybridization Assay Monitors Urothelial Cell Cancer
Semiconductor-Based Nanopore Sequencing Platform Developed for Molecular Diagnostics
Novel Assay Developed for Evaluating Fragile X Locus Repeats
Molecular Urine Test Validated for Schistosomiasis
Key Genetic Error Found in Blood Cancer Groups
Blood Test in First Trimester Predicts Fetal Gender
Next Gen Sequencing Generates High Quality Data
Oncology Biomarker Database Includes Cancer Companion Diagnostic Pathway
Molecular Tests Prevents Cervical Cancer
Diagnostic Device to Detect Many Common Human Cancers
High Throughput System Automates Human Papillomavirus HR Test
Molecular Biomarker Test Detects Sepsis
Detection of Ribonucleic Acids Improved For Molecular Diagnostics
Molecular Test Identifies Hormone-Responsive Breast Cancer
Multiplex Assay Optimized for Sexually Transmitted Bacteria
Dengue Molecular Assay Approved for Use in Brazil
Genomic Pioneer Factor Underlies Breast Cancer Progression
Genomic Blood Test Excludes Coronary Heart Disease
Technique Evaluated for Assessing Severity of Intestinal Diseases
Comprehensive Genotype Determined for Individual Cancer Cases
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.